Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:
Claus Yding Andersen: Declared no potential conflict of interest.
Daniela Cutas: Declared no potential conflict of interest.
Paul Devroey: Declared no potential conflict of interest.
Erik Ernst; Declared no potential conflict of interest.
Jens Fedder: Declared no potential conflict of interest.
Robert Fischer: Declared receipt of honoraria or consulations fees from Serono Symposia International Foundation and to be member of the Scientific Committee of Serono Symposia International Foundation.
Marie Louise Grøndahl: Declared no potential conflict of interest.
Peter Humaidan: Declared no potential conflict of interest.
Jean Noël Hugues: Declared receipt of grants and contracts from Merck Serono.
Ulrik Schiøler Kesmodel: Declared no potential conflict of interest.
Nick S. Macklon: Declared receipt of grants and contracts from Schering Plough and Merck Serono. Declared receipt of honoraria or consultation fees from Schering Plough and Merck Serono.
Robert J. Norman: Declared receipt of grants and contracts from Bayer. Declared receipt of honoraria or consultation fees from Schering Plough and Merck Serono. Declared to be member of Advisory Board, Board of Directors or other similar group of Schering Plough and Merck Serono.
Antonio Pellicer: Declared no potential conflict of interest.
Miia Savander: Declared no potential conflict of interest.
Lone Schmidt: Declared no potential conflict of interest.
Carlos Simón: Declared no potential conflict of interest.
Manuela Simoni: Declared receipt of grants and contracts from Ferring Pharmaceuticals. Declared receipt of honoraria or consultation fees from Merck Serono and Ferring Pharmaceuticals.
Peter Sjöblom: Declared no potential conflict of interest.
Allan Templeton: Declared no potential conflict of interest.
Aila Tiitinen: Declared no potential conflict of interest.
The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of August 28, 2009.
Line Bjørge
Frank J. Broekmans
Jens Fedder
Claes Gottlieb
Evangelos G. Papanikolaou
Matts Wikland
Willem Verpoest
